Search Results - Daniel Flora

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer by David Fogelman, Antonio Cubillo, Pilar García‐Alfonso, María Luisa Limón Mirón, John Nemunaitis, Daniel Flora, Christophe Borg, Laurent Mineur, Jose M. Vieitez, Allen Cohn, Gene Saylors, Albert Assad, Julie Switzky, Li Zhou, Johanna Bendell

    Published in Cancer Medicine (2018-11-01)
    Get full text
    Article


  2. 2

    T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab follow... by Monique Williams, Patrick Dillon, Harry D Bear, Andrew S Poklepovic, Maciej Kmieciak, Kandace P McGuire, Xiaoyan Deng, Dipankar Bandyopadhyay, Michael Idowu, Taylor M Jenkins, Giovanni Archer, Lindsey Gwaltney, Daniel Flora, Daniel Stover, Mary Hackney, Masey Ross, Hetal Vachhani, Raphael Louie, Amelia Grover, Tasnim Rahman, Amber Hendrix

    Published in Journal for ImmunoTherapy of Cancer (2025-02-01)
    Get full text
    Article


Search Tools: